Instructions Pelorsin oral solution 800 mg/1 g bottle 25 ml
Composition
active ingredient: 1 g of solution contains 800 mg of liquid extract from the roots of sedum pelargonium (Pelargonium sidoides) (1:8–10), extractant: ethanol 11% (m/m);
excipients: glycerin (85%).
Dosage form
Oral solution.
Main physicochemical properties: red-brown liquid with a specific odor. Turbidity may occur during storage.
Pharmacotherapeutic group
Agents affecting the respiratory system. ATX code R05.
Pharmacological properties
Pharmacodynamics.
The drug contains an extract of Pelargonium sidoides roots.
The drug affects the mechanism of attachment of bacteria and viruses to the mucous membrane, thereby preventing the penetration of viruses and bacteria into the body. The drug has a pronounced immunomodulatory effect, which causes rapid suppression of viral infection. It also prevents the reproduction of bacteria that have already penetrated the body, thereby preventing the development of complications. The drug helps to activate the mechanisms of cleansing the respiratory tract, improves the removal of viscous mucus and eliminates the conditions for further reproduction of pathogenic bacteria.
Treatment with the drug leads to rapid relief of symptoms such as cough, heavy sputum discharge, general malaise, fever, and runny nose, significantly shortens the duration of the disease, and inhibits the development of resistance in microorganisms.
Pharmacokinetics.
There are no data on the pharmacokinetics of the drug.
Indication
Acute and chronic infections of the respiratory tract and ENT organs (bronchitis, sinusitis, tonsillitis, rhinopharyngitis).
Contraindication
Hypersensitivity to the components of the drug; increased tendency to bleeding, taking medications that slow down the blood clotting process; severe liver and kidney diseases (due to lack of sufficient experience in using this drug in such cases).
Interaction with other drugs and other types of interactions.
There are no reports of interaction so far.
Due to the possible effect of Pelorsin on blood coagulation parameters, it is not excluded that, when used simultaneously, it may affect the effect of indirect anticoagulants such as warfarin.
In a placebo-controlled, double-blind clinical study in healthy volunteers, no interactions of Pelorsin with penicillin were found.
Application features
If the symptoms of the disease do not disappear within 1 week, the elevated body temperature persists for more than 3 days or the general condition worsens, or shortness of breath and bloody sputum are observed, you should immediately consult a doctor.
This medicinal product contains 11% ethanol (alcohol) m/m, i.e. 132 mg/dose (for a dose of 30 drops), which is equivalent to 2.6 ml of beer, 0.9 ml of wine per dose. Harmful for patients suffering from alcoholism. Caution should be exercised when using in children and patients with liver disease and epilepsy. The drug is not recommended for pregnant and breastfeeding women.
Use during pregnancy or breastfeeding
It is not recommended to take the drug during pregnancy or breastfeeding due to insufficient clinical experience of its use in this group of patients.
Ability to influence reaction speed when driving vehicles or other mechanisms
The effect on the reaction rate when driving or operating other mechanisms has not been studied, but it should be taken into account that the drug contains 11% (m/m) ethanol.
Method of administration and doses
The solution should be taken with a small amount of liquid 30 minutes before meals in the morning, afternoon and evening.
In the acute stage of the disease, the following are usually prescribed:
adults and children over 12 years old – 30 drops 3 times a day;
children aged 6 to 12 years - 20 drops 3 times a day;
children aged 1 to 6 years – 10 drops 3 times a day.
To prevent relapses and further treatment of chronic diseases, adults and children over 12 years of age are prescribed 10–20 drops of the drug 3 times a day.
The average duration of treatment for acute disease and prevention of relapses is 7–10 days. The total duration of treatment should not exceed 3 weeks.
Hold the bottle vertically, if necessary, tap its bottom lightly.
Children
There is no experience with the use of the drug in children under 1 year of age, therefore Pelorsin is prescribed to children over 1 year of age.
The use of Pelorsin for the treatment of young children (from 1 to 6 years old) is recommended under the supervision of a physician.
Overdose
There have been no reports of overdose so far. Adverse reactions may be exacerbated.
Adverse reactions
On the part of the digestive tract: digestive tract disorders (including stomach pain, heartburn, nausea, diarrhea), slight bleeding from the gums.
Skin/immune system disorders: hypersensitivity reactions (including skin rash, urticaria, itching of the skin and mucous membranes). In extremely rare cases, severe hypersensitivity reactions with facial swelling, shortness of breath and a decrease in blood pressure are possible).
Hepatobiliary system: increased liver function tests. A causal relationship between the increase in these tests and the use of the drug has not been demonstrated.
Expiration date
2 years.
The shelf life after opening the bottle is 3 months.
Do not use the drug after the expiration date indicated on the package.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 ° C. Do not freeze.
Keep out of reach of children.
Packaging
20 ml or 25 ml or 50 ml in a bottle. 1 bottle in a pack.
Vacation category
Without a prescription.
Producer
PJSC "Farmak".
Location of the manufacturer and its business address
Ukraine, 04080, Kyiv, Frunze St., 74.
